Our technology

Our proprietary technology combines hyperspectral analysis with artificial intelligence to classify embryos based on their metabolic profiles. We harness intrinsic signals coming from key cellular compounds, such as NADH, FAD or retinol, to define the metabolic profile of the embryos.
Our technology introduces a novel approach to imaging, combining key advancements for enhanced performance. Starting with safe multiphoton illumination in the infrared spectrum, we prioritize sample safety. Next, our use of light-sheet technology enables rapid imaging, improving efficiency and minimizing sample handling time. Finally, hyperspectral analysis adds quantitative insights, allowing detailed examination of multiple metabolites.

Benefits

  • Color-coded metabolic evaluation in minutes
  • Highly quantitative data
  • Label-free non-invasive technology
  • Single-cell segmentation of embryos
  • Live mitochondrial imaging and segmentation
  • Early detection of apoptotic cells and oxidative stress
  • Easy implementation in clinical workflow